Identification of novel BRCA2 mutations in patients with multiple primary lung cancer

view more

Image source link: https://www.techscience.com/or/v34n6/67417

Lung cancer remains the leading cause of cancer-related deaths worldwide and is generally thought to arise from mutations acquired over a lifetime through environmental exposures. However, clinicians are increasingly encountering patients with not just one, but multiple tumors in their lungs. At Fujita Health University Hospital in Japan, 7.5% (53/699 cases) of lung cancer surgeries involved patients with synchronous or metachronous multiple lung lesions, far more than would be expected. Whether these additional tumors represented cancer spreading within the lungs or reflected an inherited predisposition to developing multiple independent cancers remains unclear.

To explore this, a team of researchers led by Professor Motoshi Suzuki from the Department of Molecular Oncology, Fujita Health University, Japan, along with a graduate student Dat Quoc Tran from the Department of Molecular Oncology, Fujita Health University, Japan, employed genomic sequencing techniques. They hypothesized that hidden genetic factors, rather than chance alone, might explain at least some of these cases. Their findings were published in Volume 34 Issue 6 of the journal Oncology Research on May 21, 2026.